Mohadeseh Hashemi
University of Texas at Austin
28 Papers
28 Citations
Mohadeseh Hashemi is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Graphene & Photothermal therapy. The author has an hindex of 9, co-authored 24 publications. Previous affiliations of Mohadeseh Hashemi include Shahid Beheshti University of Medical Sciences and Health Services & University of Tehran.
Chat about Author
Papers
Layer-by-layer assembly of graphene oxide on thermosensitive liposomes for photo-chemotherapy
Mohadeseh Hashemi,Meisam Omidi,Bharadwaj Muralidharan,Lobat Tayebi,Matthew J. Herpin,Mohammad Ali Mohagheghi,Javad Mohammadi,Hugh D. C. Smyth,Thomas E. Milner +8 more
TL;DR: Study results suggest the novel dual-sensitive nanoparticles allow intracellular doxorubin delivery and respond to either acidic environments or NIR excitation.
80
Incorporation of functionalized reduced graphene oxide/magnesium nanohybrid to enhance the osteoinductivity capability of 3D printed calcium phosphate-based scaffolds
Hossein Golzar,Dorsa Mohammadrezaei,Amir Yadegari,Morteza Rasoulianboroujeni,Mohadeseh Hashemi,Meisam Omidi,Fatemeh Yazdian,Mohammad Shalbaf,Lobat Tayebi +8 more
TL;DR: 3D-printing and freeze-drying methods are applied to design an ideal scaffold for improving the osteogenic capacity of Dental pulp stem cells (DPSCs) and show that the incorporation of RMA hybrid into the scaffold can remarkably enhance its mechanical features and improve cell proliferation and differentiation simultaneously.
58
Normalization of doxorubicin release from graphene oxide: New approach for optimization of effective parameters on drug loading.
Mohadeseh Hashemi,Mohadeseh Hashemi,Amir Yadegari,Ghasem Yazdanpanah,Meisam Omidi,Sayena Jabbehdari,Fatemeh Haghiralsadat,Fatemeh Yazdian,Lobat Tayebi,Lobat Tayebi +9 more
TL;DR: It is suggested that normalization of a released drug compared with the amount of a loaded drug could be a new approach for optimization of drug loading on nanocarriers.
42
Optimizing the hybrid nanostructure of functionalized reduced graphene oxide/silver for highly efficient cancer nanotherapy
Hossein Golzar,Fatemeh Yazdian,Mohadeseh Hashemi,Meisam Omidi,Dorsa Mohammadrezaei,Hamid Rashedi,Masoumeh Farahani,Nazanin Ghasemi,Javad Shabani Shayeh,Lobat Tayebi +9 more
TL;DR: The synthesis of a novel reduced graphene oxide–silver–ploy(L-lysine) (GPA) nanohybrid is demonstrated as an efficient platform for effective cancer nanotherapy and suggests that the Her-GPA can effectively be employed as a targeted DDS allowing intracellular AgNP delivery.
22